Cancer Control Month

by | Apr 1, 2024 | Uncategorized

April is dedicated to raising awareness for cancer prevention and treatment throughout the US. 🎗️ At Plus Therapeutics, we seek to help patients and clinicians find safe, lasting solutions for treating rare and difficult-to-treat cancers....

Happy Doctor’s Day

by | Mar 30, 2024 | Uncategorized

We want to thank all of the #doctors and Principal Investigators we get to work with to help us run our #clinicaltrials and provide #treatment options for #patients! They all are great supporters of our mission to solve the toughest challenges in #oncology 🩺...

CSF-01 Implementation

by | Mar 28, 2024 | LM

In case you missed it, we announced the validation & clinical implementation of our CSF-01 Leptomeningeal Cancer Cell Diagnostic. The CSF-01 cancer cell enumeration test is an exploratory endpoint in the ReSPECT-LM Phase 1 trial that has shown promise in the...

NCCN Curtain Raiser

by | Mar 27, 2024 | LM

❗Mark Your Calendars❗ Plus Therapeutics will be presenting a poster at the National Comprehensive Cancer Network Annual Conference Press release: https://bit.ly/PSTV_PR...

Susan G. Komen: LM

by | Mar 26, 2024 | LM

Thank you to @SusanGKomen for adding “Leptomeningeal Metastasis” to your Breast Cancer Glossary patient resource! 🎗️ “Leptomeningeal Metastasis: Cancer that spreads from the original tumor to the meninges (the thin layers of tissue that cover and...